Trial · NCT03172702
Adverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 60
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Oedema peripheral | General disorders | Correction Phase | 0 | 150 | |
| other | Oedema peripheral | General disorders | Maintenance Phase | 23 | 150 | |
| other | Nasopharyngitis | Infections and infestations | Correction Phase | 1 | 150 | |
| other | Nasopharyngitis | Infections and infestations | Maintenance Phase | 36 | 150 | |
| other | Hypertension | Vascular disorders | Correction Phase | 0 | 150 | |
| other | Hypertension | Vascular disorders | Maintenance Phase | 23 | 150 | |
| other | Constipation | Gastrointestinal disorders | Correction Phase | 0 | 150 | |
| other | Constipation | Gastrointestinal disorders | Maintenance Phase | 20 | 150 | |
| serious | Diabetes mellitus | Metabolism and nutrition disorders | Correction Phase | 1 | 150 | |
| serious | Diabetes mellitus | Metabolism and nutrition disorders | Maintenance Phase | 0 | 150 | |
| serious | Pneumonia | Infections and infestations | Correction Phase | 0 | 150 | |
| serious | Pneumonia | Infections and infestations | Maintenance Phase | 3 | 150 | |
| serious | Pyelonephritis | Infections and infestations | Correction Phase | 0 | 150 | |
| serious | Pyelonephritis | Infections and infestations | Maintenance Phase | 1 | 150 | |
| serious | Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Correction Phase | 0 | 150 | |
| serious | Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Maintenance Phase | 1 | 150 | |
| serious | Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Correction Phase | 0 | 150 | |
| serious | Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Maintenance Phase | 1 | 150 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Correction Phase | 0 | 150 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Maintenance Phase | 1 | 150 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03172702/events